Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID

by

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *